Barclays’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$2.86K 5467
2025
Q2
$2.86K Buy
+100
New +$2.98K ﹤0.01% 5014
2020
Q2
Sell
-12,100
Closed -$174K 5517
2020
Q1
$174K Sell
12,100
-20,800
-63% -$371K ﹤0.01% 4409
2019
Q4
$671K Buy
32,900
+23,500
+250% +$467K ﹤0.01% 4037
2019
Q3
$183K Sell
9,400
-1,000
-10% -$21.8K ﹤0.01% 5034
2019
Q2
$234K Buy
10,400
+5,300
+104% +$145K ﹤0.01% 4969
2019
Q1
$186K Sell
5,100
-1,500
-23% -$49.5K ﹤0.01% 4877
2018
Q4
$195K Buy
6,600
+3,300
+100% +$122K ﹤0.01% 4592
2018
Q3
$140K Sell
3,300
-500
-13% -$21.7K ﹤0.01% 5278
2018
Q2
$156K Buy
3,800
+500
+15% +$22.8K ﹤0.01% 4929
2018
Q1
$191K Sell
3,300
-16,200
-83% -$948K ﹤0.01% 4866
2017
Q4
$1.07M Buy
19,500
+13,100
+205% +$669K ﹤0.01% 3061
2017
Q3
$325K Buy
6,400
+200
+3% +$10.7K ﹤0.01% 3995
2017
Q2
$359K Buy
6,200
+4,400
+244% +$256K ﹤0.01% 3846
2017
Q1
$105K Sell
1,800
-2,400
-57% -$136K ﹤0.01% 4840
2016
Q4
$233K Sell
4,200
-7,400
-64% -$396K ﹤0.01% 4093
2016
Q3
$546K Buy
11,600
+11,200
+2,800% +$533K ﹤0.01% 3142
2016
Q2
$17K Sell
400
-17,900
-98% -$738K ﹤0.01% 5330
2016
Q1
$622K Buy
+18,300
New +$723K ﹤0.01% 2949
2015
Q4
Sell
-4,400
Closed -$255K 5956
2015
Q3
$255K Sell
4,400
-99,900
-96% -$6.6M ﹤0.01% 3954
2015
Q2
$6.67M Buy
104,300
+100,700
+2,797% +$6.16M 0.01% 1284
2015
Q1
$216K Sell
3,600
-5,500
-60% -$376K ﹤0.01% 4283
2014
Q4
$527K Sell
9,100
-7,300
-45% -$372K ﹤0.01% 3818
2014
Q3
$689K Sell
16,400
-6,000
-27% -$269K ﹤0.01% 3672
2014
Q2
$1.12M Sell
22,400
-36,500
-62% -$1.68M ﹤0.01% 3220
2014
Q1
$2.59M Buy
58,900
+50,300
+585% +$2.39M ﹤0.01% 2292
2013
Q4
$344K Buy
+8,600
New +$318K ﹤0.01% 4451
2013
Q3
Sell
-9,100
Closed -$261K 7376
2013
Q2
$261K Buy
+9,100
New +$265K ﹤0.01% 4924

Other funds holding ALKS

Barclays's ALKS Position: Q1 2026 in Review

Barclays reduced its Alkermes (ALKS) stake by 69% in Q1 2026, selling an estimated $12.1M and leaving 174,983 shares worth $6.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Barclays first reported a position in ALKS in Q2 2013 and has held it in 51 quarters since. The position peaked at $19.9M in Q2 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Barclays held 174,983 shares of Alkermes worth $6.19M as of Q1 2026.
  • Barclays sold 390,050 Alkermes shares in Q1 2026, an estimated $12.1M.
  • Alkermes made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1692 holding.
  • Barclays first reported a position in Alkermes in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Alkermes position peaked at $19.9M in Q2 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.